JOENJA (leniolisib)

The JOENJA® YouTube channel features patient stories as well as educational videos, products and programs. 

JOENJA® (leniolisib) is a kinase inhibitor indicated for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older.

JOENJA is a registered trademark of Pharming Intellectual Property, B.V. Copyright ©2023 Pharming Healthcare, Inc. All rights reserved. 

Please keep in mind that the content on this page is not intended to be medical advice, as your doctor is always the best source of information for medical-related questions. Always call 911 in the event of an emergency. For additional information, including full Prescribing Information and Patient Product Information, see links below.

JOE-US-2023-0063V2 08/23